Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-17-013975
Filing Date
2017-04-24
Accepted
2017-04-24 12:02:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 31520
  Complete submission text file 0000000000-17-013975.txt   44495
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filed for) CIK: 0001348911 (see all company filings)

EIN.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations